Implications of MYC Rearrangements in Newly Diagnosed Multiple Myeloma.

Nadine H AbdallahLinda B BaughnS Vincent RajkumarPrashant KapoorMorie A GertzAngela DispenzieriMartha Q LacySuzanne R HaymanFrancis K BuadiDavid DingliRonald S GoYi L HwaAmie FonderMiriam HobbsYi LinNelson LeungTaxiarchis KourelisRahma WarsameMustaqeem SiddiquiJohn LustRobert A KyleRhett KetterlingPeter Leif BergsagelPatricia GreippShaji K Kumar

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2020)

MYC rearrangement is associated with high disease burden and is an independent adverse prognostic factor in patients with newly diagnosed multiple myeloma.

Keyphrases

newly diagnosed
multiple myeloma
prognostic factors
transcription factor
risk factors
emergency department
adverse drug
electronic health record